Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-10-20

Clinical Trial Update: SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction [Phase 1]

View source ↗

Summary

Phase 1 trial of the SeriACL device for anterior cruciate ligament reconstruction is ongoing, but the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SeriACL

Snippet

Sponsor: Serica Technologies, Inc. | Conditions: Anterior Cruciate Ligament, Knee Injuries | Phase 1 | Status: UNKNOWN